Long Noncoding RNA Expression during Human B-Cell Development

Andreas Petri(Aalborg University), Sakari Kauppinen(Aalborg University), Alexander Schmitz(Chr. Hansen (Denmark)), Hans Erik Johnsen(Herlev Hospital), Julie Støve Bødker(Chr. Hansen (Denmark)), Martin Bøgsted(Chr. Hansen (Denmark)), Karen Dybkær(Aalborg University Hospital), Charlotte Albæk Thrue(Herlev Hospital), Peter Hagedorn(Aalborg University Hospital)

PLoS ONE

September 22, 2015

10.1371/journal.pone.0138236

Cited by 104

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

|Blood|2013|683

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

|Blood|2012|396

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

|Blood|2009|390

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

|Leukemia|2012|362

MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction

|Proceedings of the National Academy of Sciences|2009|299